Monitoring Adherence in Patients With CML
Chapter 3In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the importance of discussing side effects with patients and tracking their adherence to ensure optimal outcomes.
Treatment Options for Patients with CML
In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the tyrosine kinase inhibitors available to treat patients with chronic myeloid leukemia.
Choosing the Appropriate Tyrosine Kinase Inhibitor
In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses the decision making factors related to selecting a tyrosine kinase inhibitor for individual patients.
Discontinuing Treatment in Patients With CML
In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, reviews the reasoning behind treatment discontinutation and discussing the situations where it is appropriate to stop treatment.
Managing Adverse Events in Patients With CML
In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, gives an overview of potential adverse events, including cardiovascular events, and provides insight into how they are best managed during the treatment of CML.
On the Horizon of CML Treatment
In this video Elias Jabbour, MD, an associate professor in the department of leukemia at MD Anderson Cancer Center in Houston, Texas, discusses important milestones in the treatment of CML on the horizon.
